rs199768900
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 1P and 6B. PP3BP4_StrongBP6_Moderate
The NM_003265.3(TLR3):c.2600G>A(p.Arg867Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000326 in 1,613,994 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00057 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00030 ( 1 hom. )
Consequence
TLR3
NM_003265.3 missense
NM_003265.3 missense
Scores
5
8
6
Clinical Significance
Conservation
PhyloP100: 9.35
Genes affected
TLR3 (HGNC:11849): (toll like receptor 3) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor is most abundantly expressed in placenta and pancreas, and is restricted to the dendritic subpopulation of the leukocytes. It recognizes dsRNA associated with viral infection, and induces the activation of NF-kappaB and the production of type I interferons. It thus plays a role in host defense against multiple viruses. [provided by RefSeq, Jul 2021]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
PP3
Multiple lines of computational evidence support a deleterious effect 7: Cadd, Dann, Eigen, FATHMM_MKL, phyloP100way_vertebrate, REVEL, REVEL [when BayesDel_addAF, BayesDel_noAF, max_spliceai, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.018278748).
BP6
Variant 4-186084758-G-A is Benign according to our data. Variant chr4-186084758-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 495311.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000572 AC: 87AN: 152116Hom.: 1 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
87
AN:
152116
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000648 AC: 163AN: 251418 AF XY: 0.000618 show subpopulations
GnomAD2 exomes
AF:
AC:
163
AN:
251418
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000300 AC: 439AN: 1461760Hom.: 1 Cov.: 31 AF XY: 0.000301 AC XY: 219AN XY: 727188 show subpopulations
GnomAD4 exome
AF:
AC:
439
AN:
1461760
Hom.:
Cov.:
31
AF XY:
AC XY:
219
AN XY:
727188
Gnomad4 AFR exome
AF:
AC:
0
AN:
33480
Gnomad4 AMR exome
AF:
AC:
1
AN:
44724
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26132
Gnomad4 EAS exome
AF:
AC:
0
AN:
39674
Gnomad4 SAS exome
AF:
AC:
2
AN:
86256
Gnomad4 FIN exome
AF:
AC:
326
AN:
53414
Gnomad4 NFE exome
AF:
AC:
86
AN:
1111928
Gnomad4 Remaining exome
AF:
AC:
24
AN:
60386
Heterozygous variant carriers
0
25
50
76
101
126
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000571 AC: 87AN: 152234Hom.: 1 Cov.: 33 AF XY: 0.000753 AC XY: 56AN XY: 74402 show subpopulations
GnomAD4 genome
AF:
AC:
87
AN:
152234
Hom.:
Cov.:
33
AF XY:
AC XY:
56
AN XY:
74402
Gnomad4 AFR
AF:
AC:
0.00014439
AN:
0.00014439
Gnomad4 AMR
AF:
AC:
0
AN:
0
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0.000385802
AN:
0.000385802
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0.00622877
AN:
0.00622877
Gnomad4 NFE
AF:
AC:
0.000161708
AN:
0.000161708
Gnomad4 OTH
AF:
AC:
0.000947867
AN:
0.000947867
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
80
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1Other:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Herpes simplex encephalitis, susceptibility to, 1 Benign:1
Oct 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Immunodeficiency 83, susceptibility to viral infections Other:1
Jul 12, 2021
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Pathogenic
DEOGEN2
Benign
T;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
N;N
REVEL
Pathogenic
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
D;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Mutation Taster
=48/52
disease causing
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at